课题基金 / 基金详情

Therapeutic implications of macrophage apoptosis in TB

Therapeutic implications of macrophage apoptosis in TB
巨噬细胞凋亡在结核病中的治疗意义
批准号：
279903
负责人：
Divangahi Maziar
金额：
$51.17万
依托单位：
Research Institute of the McGill University Health Centre
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2013
资助国家：
加拿大
项目状态：
已结题
起止时间：
2013-03-01 至 2018-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=279903&lang=en
关键词：
Adaptive Immunity Animal Model Cell Death Program Eicosanoids Innate Immunity Macrophages Biology Mitochondria Mycobacterium Tuberculosis Nanoparticles Pulmonary Infection

项目摘要

项目成果

Divangahi Maziar的其他基金

相似基金

相关文献

中文摘要
翻译
自从1882年德国科学家罗伯特·科赫（Robert Koch）首次发现结核病（Mycobacterium tuberculosis, Mtb）的传染因子以来，科学家们一直无法预防或治愈这种疾病。肺组织中结核分枝杆菌DNA的存在
英文摘要
Ever since German scientist Robert Koch first discovered the infectious agent of tuberculosis (TB), (Mycobacterium tuberculosis, Mtb) in 1882, TB has defied efforts by scientists to prevent or cure the disease. The presence of Mtb DNA in the lung tissues
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing a novel vaccine against COVID-19
Targeting the eicosanoid/macrophage axis to enhance host defense against influenza virus infection
Reprogramming HSCs to generate protective trained immunity against TB
Monocyte/Macrophage Biology Symposium: Cracking the Macrophage Code in Host Defense and Tolerance
海外基金